Aberrantly activated pSTAT3-ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor

Tekijä Tierney, Brent J., McCann, Georgia A., Naidu, Shan, Rath, Kellie S., Saini, Uksha, Wanner, Ross, Kuppusamy, Periannan, Suarez, Adrian, Goodfellow, Paul J., Cohn, David E., Selvendiran, Karuppaiyah
Julkaisussa Gynecol Oncol (2014)

Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor

Tekijä McCann, Georgia A., Naidu, Shan, Rath, Kellie S., Bid, Hemant K., Tierney, Brent J., Suarez, Adrian, Varadharaj, Saradhadevi, Zhang, Jianying, Hideg, Kálmán, Houghton, Peter, Kuppusamy, Periannan, Cohn, David E., Selvendiran, Karuppaiyah
Julkaisussa Oncoscience (2014)

HO-3867, a Safe STAT3 Inhibitor, Is Selectively Cytotoxic to Ovarian Cancer

Tekijä Rath, Kellie S., Naidu, Shan K., Lata, Pushpa, Bid, Hemant K., Rivera, Brian K., McCann, Georgia A., Tierney, Brent J., ElNaggar, Adam C., Bravo, Veronica, Leone, Gustavo, Houghton, Peter, Hideg, Kálmán, Kuppusamy, Periannan, Cohn, David E., Selvendiran, Karuppaiyah
Julkaisussa Cancer Res (2014)